Bio-Techne Corp

Healthcare · Biotechnology

72.40$ -0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Bio-Techne Corp (TECH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 1,215 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TECH
Line item	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	61	67	91	104	115	131	145	161	179	203	223	257	264	269	290	315	311	358	452	499	563	643	714	739	931	1,106	1,137	1,159	1,220	1,215
Cost of Revenue	17	18	25	23	28	33	35	35	37	46	47	53	55	54	65	79	79	106	145	162	188	211	241	255	298	349	367	389	429	416
Gross Profit	44	50	66	81	87	98	110	126	142	157	177	205	208	215	225	236	231	251	307	337	375	432	473	483	633	756	770	770	790	799
Research & Development	12	11	12	11	15	17	21	21	18	19	20	22	24	25	26	28	29	31	41	45	54	55	62	65	71	87	92	97	99	95
Selling, General & Administrative	15	15	17	17	18	20	19	22	24	28	31	37	33	32	36	42	43	61	119	141	153	241	237	241	290	339	352	393	415	452
Total Operating Expenses	29	28	41	41	41	46	42	44	44	48	53	60	58	58	62	72	75	92	160	186	253	296	327	326	396	460	471	563	688	547
Operating Income	15	21	25	39	46	53	68	82	98	109	124	144	151	156	163	166	158	160	147	151	122	136	126	157	237	297	299	207	102	252
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	7.4	10	22	19	14	11	11	16	8.5	5.4
Pre-Tax Income	16	22	26	39	48	38	70	83	100	111	129	154	155	156	165	162	161	161	154	147	113	126	112	276	148	301	339	186	98	241
Income Tax Expense	5.1	7.2	9.4	13	14	11	24	30	34	38	44	50	50	47	53	50	48	50	46	43	36	0.6	16	47	8.6	38	53	18	25	59
Net Income	11	15	17	27	34	27	45	53	66	73	85	104	105	110	112	112	113	111	108	104	77	125	96	229	140	272	285	168	73	182
EBITDA	18	24	37	52	59	66	74	88	104	115	137	152	159	165	174	175	173	179	184	193	182	201	212	378	250	414	457	313	217	343

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings